The Acetyl-Lysine Monoclonal Antibody (MACO0144) is a specialized antibody designed for research involving acetyl-lysine, a post-translational modification that plays a key role in gene expression regulation and signaling pathways. This monoclonal antibody, developed using innovative technology, offers high specificity and sensitivity for detecting acetyl-lysine residues in various biological samples.With its high affinity for acetyl-lysine, this antibody enables precise detection and analysis of acetylation events in proteins, providing invaluable insights into their functions and regulatory mechanisms. It is validated for use in techniques such as immunoprecipitation and immunofluorescence, making it an essential tool for researchers studying epigenetics, chromatin structure, and protein acetylation dynamics.
The acetyl-lysine monoclonal antibody is particularly valuable for studies in cell biology, molecular biology, and drug discovery, where understanding protein acetylation is essential for identifying therapeutic targets and developing novel treatments for diseases such as cancer, metabolic disorders, and neurological conditions. By enabling accurate detection and quantification of acetyl-lysine modifications, this antibody contributes to advancing research in the fields of epigenetics and proteomics.
Product Name:
Anti-Acetyl Lysine Antibody
Product Sku:
MACO0144
Size:
50ug
Host Species:
Mouse
Tested Applications:
ELISA, WB, IHC
Recommended Dilutions:
WB:1:500-1:5000, IHC:1:50-1:500
Species Reactivity:
Human, Mouse, Rat, Hamster
Immunogen:
Purified Protein
Form:
Liquid
Storage Buffer:
PBS, pH 7.4, containing 0.02% sodium azide as Preservative and 50% Glycerol.
Purification Method:
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
Clonality:
Monoclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Background:
Synonyms:
Western blot analysis of 1) Mouse Brain Tissue, 2) Hela, 3) Hela+TSA Treated using Acetyl Lysine Monoclonal Antibody.
Immunohistochemical analysis of paraffin-embedded Human Breast Carcinoma using Acetyl Lysine Monoclonal Antibody.
